Drug interactions between inhaled corticosteroids and enzymatic inhibitors

被引:35
|
作者
Daveluy, Amelie [1 ,2 ,4 ]
Raignoux, Cecile [1 ]
Miremont-Salame, Ghada [1 ,2 ,4 ]
Girodet, Pierre-Olivier [3 ,4 ]
Moore, Nicholas [2 ,3 ,4 ]
Haramburu, Francoise [1 ,2 ,4 ]
Molimard, Mathieu [2 ,3 ,4 ]
机构
[1] Hop Pellegrin, Ctr Reg Pharmacovigilance, F-33076 Bordeaux, France
[2] INSERM, U657, Bordeaux, France
[3] Univ Victor Segalen, Bordeaux, France
[4] CHU Bordeaux, Dept Pharmacol, Bordeaux, France
关键词
Drug interactions; Fluticasone; Budesonide; Beclomethasone; Cushing's syndrome; Adrenal insufficiency; CUSHINGS-SYNDROME; PLASMA-CONCENTRATIONS; ORAL METHYLPREDNISOLONE; ADRENAL INSUFFICIENCY; ITRACONAZOLE; BUDESONIDE; FLUTICASONE; SUPPRESSION; SECONDARY; INCREASE;
D O I
10.1007/s00228-009-0653-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:743 / 745
页数:3
相关论文
共 50 条
  • [11] Antiretroviral therapies and corticosteroids Drug-drug interactions
    Cadet, Myriam Jean
    NURSE PRACTITIONER, 2021, 46 (12): : 40 - 47
  • [12] GUIDANCE ON INHALED CORTICOSTEROIDS Inhaled corticosteroids: first do no harm
    Mak, Vincent H. F.
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [13] Drug Interactions With Oral Inhaled Medications
    Ajimura, Chanelle M.
    Jagan, Nikhil
    Morrow, Lee E.
    Malesker, Mark A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (06) : 273 - 280
  • [14] Interactions between corticosteroids and β agonists
    Taylor, DR
    Hancox, RJ
    THORAX, 2000, 55 (07) : 595 - 602
  • [15] Discrepancies Between GEMA And GINA In The Classification Of Inhaled Corticosteroids
    Entrenas Costa, Luis Manuel
    Entrenas Castillo, Marta
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (12): : 667 - 667
  • [16] ASSOCIATION BETWEEN INHALED CORTICOSTEROIDS AND PNEUMONIA IN ASTHMA PATIENTS
    Cho, Y. J.
    Kim, M.
    Rhee, C. K.
    Kim, K.
    Yoo, K. H.
    Jung, K.
    Lee, J. H.
    VALUE IN HEALTH, 2018, 21 : S231 - S231
  • [17] Discrepancies Between GEMA and GINA in the Classification of Inhaled Corticosteroids
    Plaza Moral, Vicente
    Gomez-Outes, Antonio
    Quirce Gancedo, Santiago
    Alobid, Isam
    Alvarez Rodriguez, Cesare
    Blanco Aparicio, Marina
    Garcia, Gabriel
    Gomez Ruiz, Fernando
    Hidalgo Requena, Antonio
    Korta Murua, Javier
    Molina Paris, Jesus
    Pellegrini Belinchon, Francisco J.
    Perez Encinas, Montserrat
    Plaza Zamora, Javier
    Praena Crespo, Manuel
    Sanchez Pina, Concha
    Sanz Ortega, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (07): : 472 - 473
  • [18] Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system
    Katarzyna Lubelska
    Małgorzata Milczarek
    Karolina Modzelewska
    Jolanta Krzysztoń-Russjan
    Krzysztof Fronczyk
    Katarzyna Wiktorska
    Pharmacological Reports, 2012, 64 : 1243 - 1252
  • [19] Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system
    Lubelska, Katarzyna
    Milczarek, Malgorzata
    Modzelewska, Karolina
    Krzyszton-Russjan, Jolanta
    Fronczyk, Krzysztof
    Wiktorska, Katarzyna
    PHARMACOLOGICAL REPORTS, 2012, 64 (05) : 1243 - 1252
  • [20] Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors
    Benoit Chauvin
    Sylvain Drouot
    Aurélie Barrail-Tran
    Anne-Marie Taburet
    Clinical Pharmacokinetics, 2013, 52 : 815 - 831